Besançon, A., Goncalves, T., Valette, F., Dahllöf, M., Mandrup-Poulsen, T., Chatenoud, L., & You, S. (2018). Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice. Diabetologia, 61(2), 389-398. https://doi.org/10.1007/s00125-017-4459-0 (Original work published 2018)